Clinical Trial Update: Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the efficacy and safety of Valsartan alone and in combination with Nebivolol for hypertensive patients with left ventricular hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Nebivolol (Nebivolol)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Trinity Hypertension & Metabolic Research Institute | Conditions: Hypertension Complicated, Hypertrophy, Left Ventricular | Phase 4 | Status: COMPLETED